
AI and Data for Cancer Therapeutics
Origin is producing matched spatial molecular, histopathology imaging, and clinical datasets using cancer tissue samples excised from real patients. We operate our own laboratories, and source tumour samples from leading biobanks.
We believe cancer is a disease ideally suited to be modelled using deep learning, however, we're largely missing the right kind of data at scale. Our initial bet is on spatial biology, helping capture the role of localisation of molecules in 3D, elucidating cell-cell signalling, differentially enriched pathways across regions, and varying cellular composition. This is particularly valuable for validating biomarkers, identifying targets and diagnostics.
As R&D increasingly relies on frontier AI systems, we need to collect real-world evidence at scale to ensure model driven findings translate in the clinic.